Clinical Trial Update: A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance ADAPT therapy with capecitabine and celecoxib in metastatic colorectal cancer; the study was terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Celecoxib (Celecoxib)

Snippet

Sponsor: University of Washington | Conditions: Recurrent Colon Carcinoma, Recurrent Rectal Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2017-12-02